Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Thorac Oncol. 2018 Nov 1;14(3):540–546. doi: 10.1016/j.jtho.2018.10.152

Table 2.

Treatment Outcomes

PET Nonresponders (n = 41)
All Patients
(n = 111), %
PET Responders
(n = 70), %
No chemotherapy
Change (n = 16), %
Chemotherapy
Change (n = 25), %
Clinical CR
 Yes 82 (74) 59 (84) 8 (50) 15 (60)
 No 24 (23) 8 (11) 6 (37.5) 10 (40)
 N/A 5 (4.5) 3 (4) 2 (12.5) -
Surgery
 Yes 31 (27) 22 (31) 5 (31) 4 (16)
 No 80 (72) 48 (68.6) 11 (69) 21 (84)
R0 resection (n = 31)
 Yes 30 (97) 21 (100) 5 (100) 4 (80)
 No 1 (3) 0 0 1 (20)
Pathologic CR (n = 31)
 Yes 8 (26) 7 (32) 0 1 (25)
 No 23 (74) 15 (68) 5 (100) 3 (75)

Values are shown as n (%) unless otherwise noted.

CR, complete response; PET, positron-emission tomography; N/A, not available